This “tease” isn’t from a regular ad, it’s from a “free” article that Porter Stansberry posted earlier this week… but a couple readers asked about it, and I was curious myself, so I jumped in to check out the clues. Maybe it’s just that this ad hints at a non-sexy and rational-sounding investment at a […]
Articles
I’ve gotten quite a few questions recently about “income” and “buy stocks cheap” letters that are clearly veiled hints about put option selling… so I thought I’d take a look at one of them. The ad in question today is from Karim Rahemtulla, who calls himself “The Frugal Millionaire” in this spiel and has been […]
We’re all growing more and more immune to hyperbole, I hope, but the combination of hype-filled newsletter pitches, shallow commentary from attention whores on CNBC, and clickbait headlines is enough to put you off investing in the market at all… how many times can you hear words like “collapse” and “beaten down” and “nightmare” applied […]
Frank Curzio has graced the pages of Gumshoe quite a few times over the years, under the aegis of several different publishers, but this is the first time he has actively promoted his new self-published “front end” newsletter, Curzio Research Advisory (he launched his “back end” newsletter, Curzio Venture Opportunities, late last year). I don’t […]
Newsletter copywriters are no different from other marketers: they will do whatever it takes to get attention by playing off of something or someone that has celebrity or notoriety. In the past that’s meant implying that some big celebrity investor has a connection to a “secret” stock or technique, or that someone high up in […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, choses his own topics, and his words and opinions are his own. You can see his past columns and most recent comments on his Stock Gumshoe page.] We first presented Gilead ($GILD) as a long idea […]
This ad is a re-hashing of a recommendation that Bill Patalon’s Private Briefing was touting back in October of 2015 — so I’m re-publishing the piece below so you can see the details about the company. It has not been updated or revised since 10/30/15. The ad has changed considerably since last Fall — back […]
This ad about a “Donald Trump investment” is sending a lot of questions our way, so we’re going to take a look at it for you in today’s Friday File… and I’ve also got an update on Sandstorm Gold to share, plus a quick look at the idea of “protection” from market declines and how […]
It’s been a heckuva week, eh? I have no idea whether this is really the “capitulation” washout that so many investing pundits have been looking for, or whether we’ll keep falling on Monday or will bounce back after the week ended so roughly, but I do have a couple thoughts to share with you about […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. His bio, past articles, and most recent comments can be seen here. Enjoy!] OUTÂ of the night that covers me, Black as the Pit from pole to pole, I thank […]
Several eager readers have forwarded along this teaser, which started running in the last week or so and which pitches a way to profit from the big infrastructure investments that will be made around the world in the coming years. The ad is for Jeff Siegel’s Power Portfolio over at Angel Publishing, a newsletter which […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I singed on a CRA intro newsletter when it first came out. Canceled immediately after 1 year. I liked his podcast and h...
While TSLA & T have their problems, they're focused on a primary business. I think Stansberry is hinting at a conglomer...
Travis, You are spot on regarding long term care insurance. As an attorney I was threatened by a LTC agent (for GE) to ...
I too was, yes past tense wass , when he recommended GE, which I owned already, but bought some more. It kept going dow...
Wife and I have LTC from GE. Our total premium went up from $3300 per year to $5000 per year in November 2018...
Sounds like you like to gamble, so I recommend GE, SIG, or IQ for an easy double. Put $800 in each stock using a discoun...
I like Curzios style, but he’s had some real hand Grenade stock picks this year (GE, DBD) for example. I agree abou...
GE massive debt will sink the ship. Porter Stansberry has long back declared that GE could be the next Enron. Why regret...
I'm wondering if GE is the next Lehman. A 1 million pound canary in the coalman indicating how much debt has gone into g...
The other big bank is GE.......
STAY AWAY from CRA. I couldn't figure out how to update my original post, so I'll add this one. By my count, Frank h...
the tech side of the market is rarely valued on dividends (income) and always valued on growth. that is the Micron dilem...
Selling is hard, especially when you have to admit that you were wrong in an idea you were really sure about. I havenâ€...
Any thoughts on a good entry point for long term GE investing on a very limited budget? Now that the share price is in t...